Victoria A Kumar1, Margo A Sidell, Wan-Ting Yang, Jason P Jones. 1. Department of Internal Medicine,1 Division of Nephrology, Southern California Permanente Medical Group, Los Angeles, and Research and Evaluation,2 Southern California Permanente Medical Group, Pasadena, California, USA.
Abstract
INTRODUCTION: Many clinicians perceive that peritoneal dialysis (PD) should be reserved for younger, healthier, more affluent patients. Our aim was to examine outcomes for PD patients in a managed care setting and to identify predictors of adverse outcomes. METHODS: We identified all patients who initiated PD at our institution between 1 January 2001 and 31 December 2010. Predictor variables studied included age, sex, race, PD modality, cause of end-stage renal disease (ESRD), dialysis vintage, Charlson comorbidity index (CCI) score, education, and income level. Poisson models were used to determine the relative risk (RR) of peritonitis and the number of hospital days per patient-year. The log-rank test was used to compare technique survival by patient strata. RESULTS: Among the 1378 patients who met the inclusion criteria, only female sex [RR: 0.85; 95% confidence interval (CI): 0.74 to 0.98; p = 0.02] and higher education (RR: 0.77; 95% CI: 0.60 to 0.98; p = 0.04) were associated with peritonitis. For hospital days, dialysis vintage (RR: 1.11; 95% CI: 1.04 to 1.18; p = 0.002), CCI score (RR: 1.06; 95% CI: 1.02 to 1.20; p = 0.002), and cause of ESRD (RR for glomerulonephritis: 0.59; 95% CI: 0.43 to 0.80; p = 0.0006; and RR for hypertension: 0.69; 95% CI: 0.55 to 0.88; p = 0.002) were associated with 1 extra hospital day per patient-year. The 2-year technique survival was 61% for patients who experienced at least 1 episode of peritonitis and 72% for those experiencing no peritonitis (p = 0.0001). Baseline patient age, primary cause of ESRD, and PD modality were the only other variables associated with technique survival in the study. CONCLUSIONS: Neither race nor socio-economic status predicted technique survival or hospital days in our study. Female sex and higher education were the only two variables studied that had an association with peritonitis.
INTRODUCTION: Many clinicians perceive that peritoneal dialysis (PD) should be reserved for younger, healthier, more affluent patients. Our aim was to examine outcomes for PDpatients in a managed care setting and to identify predictors of adverse outcomes. METHODS: We identified all patients who initiated PD at our institution between 1 January 2001 and 31 December 2010. Predictor variables studied included age, sex, race, PD modality, cause of end-stage renal disease (ESRD), dialysis vintage, Charlson comorbidity index (CCI) score, education, and income level. Poisson models were used to determine the relative risk (RR) of peritonitis and the number of hospital days per patient-year. The log-rank test was used to compare technique survival by patient strata. RESULTS: Among the 1378 patients who met the inclusion criteria, only female sex [RR: 0.85; 95% confidence interval (CI): 0.74 to 0.98; p = 0.02] and higher education (RR: 0.77; 95% CI: 0.60 to 0.98; p = 0.04) were associated with peritonitis. For hospital days, dialysis vintage (RR: 1.11; 95% CI: 1.04 to 1.18; p = 0.002), CCI score (RR: 1.06; 95% CI: 1.02 to 1.20; p = 0.002), and cause of ESRD (RR for glomerulonephritis: 0.59; 95% CI: 0.43 to 0.80; p = 0.0006; and RR for hypertension: 0.69; 95% CI: 0.55 to 0.88; p = 0.002) were associated with 1 extra hospital day per patient-year. The 2-year technique survival was 61% for patients who experienced at least 1 episode of peritonitis and 72% for those experiencing no peritonitis (p = 0.0001). Baseline patient age, primary cause of ESRD, and PD modality were the only other variables associated with technique survival in the study. CONCLUSIONS: Neither race nor socio-economic status predicted technique survival or hospital days in our study. Female sex and higher education were the only two variables studied that had an association with peritonitis.
Authors: Kleyton de Andrade Bastos; Abdul Rashid Qureshi; Antonio Alberto Lopes; Natália Fernandes; Luciana Mendonça M Barbosa; Roberto Pecoits-Filho; José Carolino Divino-Filho Journal: Clin J Am Soc Nephrol Date: 2011-06-23 Impact factor: 8.237
Authors: Mala Chidambaram; Joanne M Bargman; Robert R Quinn; Peter C Austin; Janet E Hux; Andreas Laupacis Journal: Perit Dial Int Date: 2010-10-14 Impact factor: 1.756
Authors: Enrique Rojas-Campos; Mario Alcántar-Medina; Laura Cortés-Sanabria; Héctor R Martínez-Ramírez; José L Camarena; Salvador Chávez; Antonio Flores; Juan J Nieves; Francisco Monteón; Benjamin Gómez-Navarro; Alfonso M Cueto-Manzano Journal: Rev Invest Clin Date: 2007 May-Jun Impact factor: 1.451
Authors: Bernard G Jaar; Laura C Plantinga; Deidra C Crews; Nancy E Fink; Nasser Hebah; Josef Coresh; Alan S Kliger; Neil R Powe Journal: BMC Nephrol Date: 2009-02-06 Impact factor: 2.388
Authors: Rajnish Mehrotra; Melissa Soohoo; Matthew B Rivara; Jonathan Himmelfarb; Alfred K Cheung; Onyebuchi A Arah; Allen R Nissenson; Vanessa Ravel; Elani Streja; Sooraj Kuttykrishnan; Ronit Katz; Miklos Z Molnar; Kamyar Kalantar-Zadeh Journal: J Am Soc Nephrol Date: 2015-12-10 Impact factor: 10.121
Authors: Amanda L McGuire; Sophia C Bennett; Sally M Lansley; Natalia D Popowicz; Julius F Varano della Vergiliana; Daniel Wong; Y C Gary Lee; Aron Chakera Journal: PLoS One Date: 2015-03-05 Impact factor: 3.240